Biocon Biologics partners with Civica to expand Insulin Aspart access in United States
- Posted on March 6, 2025
- By Financial Express
- 5 Views
Biocon Biologics partners with Civica to expand Insulin Aspart access in United States
Biocon Biologics and Civica, Inc. have joined forces to make Insulin Aspart more accessible and affordable in the US. Biocon Biologics will supply the drug substance and Civica will produce the drug product at their Virginia facility, making it available to patients after clinical trials.
